TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15488 · Feb 13

#swift#analysis#analytics#cocoapods#crashlytics#debug#debugger#debugging#hacktoberfest#layout_debugger#leak_detection#log#logs_analysis#networking#performance_analysis#sandbox#swift#swift6#ui#uikit#view DebugSwift is a comprehensive toolkit that simplifies debugging for Swift iOS apps by providing real-time monitoring of network requests, performance metrics (CPU, memory, FPS), crash reports, and app resources like keychain and user defaults. It includes interface tools for visualizing layouts with grid overlays and touch indicators, plus memory leak detection and console logging. The main benefit is that you can quickly identify and fix issues during development without leaving your app—just shake your device to toggle the debug panel, making troubleshooting faster and more efficient. https://github.com/DebugSwift/DebugSwift

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment